FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2008385909> ?p ?o ?g. }

• W2008385909 endingPage "3338" @default.
• W2008385909 startingPage "3337" @default.
• W2008385909 abstract "Gatifloxacin is a recently marketed quinolone with an enhanced activity against gram-positive bacteria compared with that of ciprofloxacin (4, 12, 13, 18). The structural differences between gatifloxacin and ciprofloxacin are substituents at the C-8 position of the quinolone nucleus (gatifloxacin, C-8-methoxy; ciprofloxacin, C-8-H) and at the C-3′ position of the piperazinyl moiety of the C-7 position (gatifloxacin, C-3′-methyl; ciprofloxacin, C-3′-H). Several studies have directed attention to substituents at the C-8 position of the quinolone nucleus (1, 2, 5-10, 14, 15, 19, 20). Introduction of the methoxy group at the C-8 position was thought to ensure potent activity against gram-positive bacteria (2, 6, 9, 20). However, there have been few studies on the effect of C-8 substituents against type II topoisomerases. Thus, to investigate the effect of the C-8 and C-3′ substituents of gatifloxacin against type II topoisomerases in Staphylococcus aureus, the activities of the quinolones AM-1121 (C-8-H, C-3′-methyl) and AM-1147 (C-8-methoxy, C-3′-H), which are structurally related to gatifloxacin,​gatifloxacin, were compared with those of gatifloxacin and ciprofloxacin.TABLE 1.Target inhibition and antibacterial activity of gatifloxacin and its related compoundsThe quinolones tested were synthesized in-house. The bacterial strain used in this study was the quinolone-susceptible clinical isolate S. aureus MS5935 (3). MICs were determined by using agar dilution methodology according to NCCLS guidelines (11).The GyrA and GyrB subunits of DNA gyrase and the GrlA and GrlB subunits of topoisomerase IV of MS5935 were prepared by a method described previously (16, 17). The activities of each enzyme were determined by a method described previously (16, 17). The effects of the quinolones were evaluated based on the concentrations required to inhibit 50% of the enzyme reaction (IC50s).The IC50s of C-8-methoxy compounds (gatifloxacin and AM-1147) against topoisomerase IV were almost equal to those of their C-8-H counterparts (AM-1121 and ciprofloxacin), whereas the inhibitory activities of C-8-methoxy compounds against DNA gyrase were about six times higher than those of their C-8-H counterparts (Table ​(Table1;1; Fig. ​Fig.1).1). The C-3′-methyl moiety had little effect on the inhibitory activity against both DNA gyrase and topoisomerase IV. These results indicate that introduction of the C-8-methoxy group to the quinolone ring enhances the inhibitory activity against DNA gyrase without exerting influence on topoisomerase IV inhibition.FIG. 1.Inhibitory activities of gatifloxacin and its related compounds against topoisomerase IV (A) and DNA gyrase (B).The C-8-methoxy compounds showed two- to fourfold-lower MICs than their C-8-H counterparts. On the other hand, the antibacterial activities of C-3′-methyl compounds were similar or slightly superior to those of their C-3′-H counterparts. These results indicate that the C-8-methoxy group of these compounds has a greater effect on the increment of the activity against the wild-type strain, whereas the C-3′-methyl group is slightly involved in the increment of this activity.It was previously reported that the inhibition of both target enzymes contributes to the antibacterial activities of quinolones because the antibacterial activities of most quinolones were decreased by both the grlA and gyrA mutations (17). Therefore, it is suggested that an increase in the inhibitory activity of the C-8-methoxy compounds against DNA gyrase is the possible mechanism underlying their potent antibacterial activity.In summary, introduction of the methoxy group at the C-8position of the quinolone nucleus enhances inhibitory activity against DNA gyrase, leading to the potent activity of gatifloxacin against S. aureus." @default.
• W2008385909 created "2016-06-24" @default.
• W2008385909 creator A5005110548 @default.
• W2008385909 creator A5029219896 @default.
• W2008385909 creator A5038328598 @default.
• W2008385909 creator A5055644938 @default.
• W2008385909 creator A5069687119 @default.
• W2008385909 creator A5070370776 @default.
• W2008385909 date "2002-10-01" @default.
• W2008385909 modified "2023-09-25" @default.
• W2008385909 title "Contribution of the C-8-Methoxy Group of Gatifloxacin to Inhibition of Type II Topoisomerases of Staphylococcus aureus" @default.
• W2008385909 cites W1819382944 @default.
• W2008385909 cites W1985235810 @default.
• W2008385909 cites W2007187611 @default.
• W2008385909 cites W2073859002 @default.
• W2008385909 cites W2098189336 @default.
• W2008385909 cites W2102055645 @default.
• W2008385909 cites W2108993657 @default.
• W2008385909 cites W2109729152 @default.
• W2008385909 cites W2112633093 @default.
• W2008385909 cites W2113146658 @default.
• W2008385909 cites W2121411057 @default.
• W2008385909 cites W2131246631 @default.
• W2008385909 cites W2134667855 @default.
• W2008385909 cites W2141382307 @default.
• W2008385909 cites W2141882959 @default.
• W2008385909 cites W2142124574 @default.
• W2008385909 cites W2163645760 @default.
• W2008385909 cites W2168646139 @default.
• W2008385909 cites W2169920555 @default.
• W2008385909 doi "https://doi.org/10.1128/aac.46.10.3337-3338.2002" @default.
• W2008385909 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/128794" @default.
• W2008385909 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12234876" @default.
• W2008385909 hasPublicationYear "2002" @default.
• W2008385909 type Work @default.
• W2008385909 sameAs 2008385909 @default.
• W2008385909 citedByCount "7" @default.
• W2008385909 countsByYear W20083859092014 @default.
• W2008385909 countsByYear W20083859092015 @default.
• W2008385909 countsByYear W20083859092020 @default.
• W2008385909 crossrefType "journal-article" @default.
• W2008385909 hasAuthorship W2008385909A5005110548 @default.
• W2008385909 hasAuthorship W2008385909A5029219896 @default.
• W2008385909 hasAuthorship W2008385909A5038328598 @default.
• W2008385909 hasAuthorship W2008385909A5055644938 @default.
• W2008385909 hasAuthorship W2008385909A5069687119 @default.
• W2008385909 hasAuthorship W2008385909A5070370776 @default.
• W2008385909 hasBestOaLocation W20083859092 @default.
• W2008385909 hasConcept C147897179 @default.
• W2008385909 hasConcept C185592680 @default.
• W2008385909 hasConcept C2777653605 @default.
• W2008385909 hasConcept C2778512257 @default.
• W2008385909 hasConcept C2779288629 @default.
• W2008385909 hasConcept C2779489039 @default.
• W2008385909 hasConcept C501593827 @default.
• W2008385909 hasConcept C523546767 @default.
• W2008385909 hasConcept C54355233 @default.
• W2008385909 hasConcept C552990157 @default.
• W2008385909 hasConcept C55493867 @default.
• W2008385909 hasConcept C71924100 @default.
• W2008385909 hasConcept C86803240 @default.
• W2008385909 hasConcept C89423630 @default.
• W2008385909 hasConcept C98274493 @default.
• W2008385909 hasConceptScore W2008385909C147897179 @default.
• W2008385909 hasConceptScore W2008385909C185592680 @default.
• W2008385909 hasConceptScore W2008385909C2777653605 @default.
• W2008385909 hasConceptScore W2008385909C2778512257 @default.
• W2008385909 hasConceptScore W2008385909C2779288629 @default.
• W2008385909 hasConceptScore W2008385909C2779489039 @default.
• W2008385909 hasConceptScore W2008385909C501593827 @default.
• W2008385909 hasConceptScore W2008385909C523546767 @default.
• W2008385909 hasConceptScore W2008385909C54355233 @default.
• W2008385909 hasConceptScore W2008385909C552990157 @default.
• W2008385909 hasConceptScore W2008385909C55493867 @default.
• W2008385909 hasConceptScore W2008385909C71924100 @default.
• W2008385909 hasConceptScore W2008385909C86803240 @default.
• W2008385909 hasConceptScore W2008385909C89423630 @default.
• W2008385909 hasConceptScore W2008385909C98274493 @default.
• W2008385909 hasIssue "10" @default.
• W2008385909 hasLocation W20083859091 @default.
• W2008385909 hasLocation W20083859092 @default.
• W2008385909 hasLocation W20083859093 @default.
• W2008385909 hasOpenAccess W2008385909 @default.
• W2008385909 hasPrimaryLocation W20083859091 @default.
• W2008385909 hasRelatedWork W1534721004 @default.
• W2008385909 hasRelatedWork W2008385909 @default.
• W2008385909 hasRelatedWork W2033978225 @default.
• W2008385909 hasRelatedWork W2111250585 @default.
• W2008385909 hasRelatedWork W2189979093 @default.
• W2008385909 hasRelatedWork W2415156928 @default.
• W2008385909 hasRelatedWork W2941379658 @default.
• W2008385909 hasRelatedWork W4545852 @default.
• W2008385909 hasRelatedWork W48517024 @default.
• W2008385909 hasRelatedWork W972506011 @default.
• W2008385909 hasVolume "46" @default.
• W2008385909 isParatext "false" @default.
• W2008385909 isRetracted "false" @default.
• W2008385909 magId "2008385909" @default.

• next